- Home
- ENTO vs SBET Comparison
ENTO vs SBET Comparison
Compare ENTO & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTO
- SBET
- Stock Information
- Founded
- ENTO 2014
- SBET 1995
- Country
- ENTO United States
- SBET United States
- Employees
- ENTO 2
- SBET N/A
- Industry
- ENTO Biotechnology: Pharmaceutical Preparations
- SBET Computer Software: Prepackaged Software
- Sector
- ENTO Health Care
- SBET Technology
- Exchange
- ENTO Nasdaq
- SBET Nasdaq
- Market Cap
- ENTO 1.7M
- SBET 1.8M
- IPO Year
- ENTO 2016
- SBET 1997
- Fundamental
- Price
- ENTO $0.36
- SBET $0.27
- Analyst Decision
- ENTO
- SBET
- Analyst Count
- ENTO 0
- SBET 0
- Target Price
- ENTO N/A
- SBET N/A
- AVG Volume (30 Days)
- ENTO 1.4M
- SBET 1.7M
- Earning Date
- ENTO 05-20-2025
- SBET 05-16-2025
- Dividend Yield
- ENTO N/A
- SBET N/A
- EPS Growth
- ENTO N/A
- SBET N/A
- EPS
- ENTO N/A
- SBET 2.93
- Revenue
- ENTO N/A
- SBET $3,662,349.00
- Revenue This Year
- ENTO N/A
- SBET N/A
- Revenue Next Year
- ENTO N/A
- SBET N/A
- P/E Ratio
- ENTO N/A
- SBET $0.16
- Revenue Growth
- ENTO N/A
- SBET N/A
- 52 Week Low
- ENTO $0.19
- SBET $0.19
- 52 Week High
- ENTO $3.24
- SBET $1.31
- Technical
- Relative Strength Index (RSI)
- ENTO 38.33
- SBET 49.14
- Support Level
- ENTO $0.38
- SBET $0.19
- Resistance Level
- ENTO $0.39
- SBET $0.24
- Average True Range (ATR)
- ENTO 0.04
- SBET 0.04
- MACD
- ENTO -0.00
- SBET 0.01
- Stochastic Oscillator
- ENTO 18.24
- SBET 55.17
About ENTO Entero Therapeutics Inc. Common Stock
Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.